Skip to main content
Healthcare

STAT+: Mark Cuban wants to crack open the market for rare disease treatments

STAT+: Mark Cuban wants to crack open the market for rare disease treatments

Feed excerpt — reported by STAT News

Mark Cuban's Cost Plus Drugs seeks to reduce manufacturing costs for custom rare disease drugs and n-of-1 gene therapies with new fill-finish plant in Dallas.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.